K H Mayer|S M Opal - JoVE Visualize

Showing results (161-170 of 238) with videos related to

Pageof 24

Sort By:

The American Journal of Medicine|July 23, 1998

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) GroupP Schuman, S E Ohmit, J D Sobel, et al.

Family Planning Perspectives|August 15, 2000

Acceptability of a novel vaginal microbicide during a safety trial among low-risk womenM E Bentley, K M Morrow, A Fullem, et al.

International Journal of STD & AIDS|June 23, 2005

HIV in couples in South India; implications for preventionM Chatterjee Rogers, G Gopalakrishnan, N Kumarasamy, et al.

AIDS Care|December 13, 2023

Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBSJ S Lee, A W Batchelder, A M Stanton, et al.

AIDS and Behavior|November 10, 2023

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on StudyK R Amico, K H Mayer, R J Landovitz, et al.

The Journal of Infectious Diseases|May 1, 1996

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.

Critical Care Medicine|March 1, 1993

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study GroupC J Fisher, S M Opal, J F Dhainaut, et al.

JAMA|September 8, 1993

The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United StatesK H Mayer, J Peipert, T Fleming, et al.

AIDS and Behavior|April 3, 2020

HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United StatesB O Ojikutu, N Amutah-Onukagha, T F Mahoney, et al.

Pageof 24

Showing results (161-170 of 238) with videos related to

Sort By:

Pageof 24

The American Journal of Medicine|July 23, 1998

Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) GroupP Schuman, S E Ohmit, J D Sobel, et al.

Family Planning Perspectives|August 15, 2000

Acceptability of a novel vaginal microbicide during a safety trial among low-risk womenM E Bentley, K M Morrow, A Fullem, et al.

International Journal of STD & AIDS|June 23, 2005

HIV in couples in South India; implications for preventionM Chatterjee Rogers, G Gopalakrishnan, N Kumarasamy, et al.

AIDS Care|December 13, 2023

Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBSJ S Lee, A W Batchelder, A M Stanton, et al.

AIDS and Behavior|November 10, 2023

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on StudyK R Amico, K H Mayer, R J Landovitz, et al.

The Journal of Infectious Diseases|May 1, 1996

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremiaA K Bhattacharjee, S M Opal, R Taylor, et al.

Critical Care Medicine|March 1, 1993

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study GroupC J Fisher, S M Opal, J F Dhainaut, et al.

JAMA|September 8, 1993

The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysisW A Knaus, F E Harrell, C J Fisher, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United StatesK H Mayer, J Peipert, T Fleming, et al.

AIDS and Behavior|April 3, 2020

HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United StatesB O Ojikutu, N Amutah-Onukagha, T F Mahoney, et al.

Pageof 24